Skip to main content
. 2017 Dec 27;117:200–208. doi: 10.1016/j.rvsc.2017.12.015

Fig. 2.

Fig. 2

Proportion of positive Cryptosporidium spp. faecal samples with different halofuginone lactate (HL) treatment category: (white) not treated (n = 34); (black) treatment start was delayed or duration was < 7 days (n = 45); (blue) treatment was done correctly (started in the first 48 h of life and lasted ≥ 7 days of treatment) (n = 65). Total proportion of diarrhoeic faecal samples presented as grey area in the background.